Centogene N.V.
DelistedCIK 1757097fmd_1B90ZAF5T2YP9QXQS9RV6SMFHPServices · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2017 to Dec 31, 2023, 19 periods
Latest annual · FY2023
Millions- Total revenues
- 49
- Gross profit
- 17
- Operating income
- (30)
- Net income
- (36)
- Free cash flow
- (32)
Latest quarter · Q2 FY2022
Millions- Total revenues
- 11
- Gross profit
- 5
- Operating income
- (11)
- Net income
- (10)
- Free cash flow
- (6)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +8.1%
- Revenue, 5 yearsFY2018 to FY2023
- +3.7%
- Net income, 5 yearsFY2018 to FY2023
- n/m
Centogene N.V. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | €48.5 million | €47.5 million | +2.2% | 20-F 2024-05-15 · proof |
| Gross profit | €17.2 million | €19.8 million | -12.7% | 20-F 2024-05-15 · proof |
| Operating income | -€29.7 million | -€36.8 million | 20-F 2024-05-15 · proof | |
| Net income | -€35.5 million | -€31.8 million | 20-F 2024-05-15 · proof | |
| Cash from operating activities | -€31.7 million | -€26.5 million | 20-F 2024-05-15 · proof | |
| Free cash flow | -€31.8 million | -€26.9 million | 20-F 2024-05-15 · proof | |
| Total assets | €77.2 million | €92.8 million | -16.9% | 20-F 2024-05-15 · proof |
| Total liabilities | €102.4 million | €85.4 million | +19.9% | 20-F 2024-05-15 · proof |
| Cash and cash equivalents | €19.1 million | €36 million | -46.9% | 20-F 2024-05-15 · proof |
| Total debt | €65.8 million | €44.7 million | +47.2% | 20-F 2024-05-15 · proof |
- What was Centogene N.V.'s revenue in fiscal 2023?
- Centogene N.V. reported revenue of €48.5 million for fiscal 2023 (the year ended Dec 31, 2023), against €47.5 million the year before (+2.2%). Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What was Centogene N.V.'s gross profit in fiscal 2023?
- Centogene N.V. reported gross profit of €17.2 million for fiscal 2023 (the year ended Dec 31, 2023), against €19.8 million the year before (-12.7%). Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What was Centogene N.V.'s operating income in fiscal 2023?
- Centogene N.V. reported operating income of -€29.7 million for fiscal 2023 (the year ended Dec 31, 2023), against -€36.8 million the year before. Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What was Centogene N.V.'s net income in fiscal 2023?
- Centogene N.V. reported net income of -€35.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -€31.8 million the year before. Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What was Centogene N.V.'s cash from operating activities in fiscal 2023?
- Centogene N.V. reported cash from operating activities of -€31.7 million for fiscal 2023 (the year ended Dec 31, 2023), against -€26.5 million the year before. Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What was Centogene N.V.'s free cash flow in fiscal 2023?
- Centogene N.V. reported free cash flow of -€31.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -€26.9 million the year before. Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What are Centogene N.V.'s total assets?
- As of Dec 31, 2023, Centogene N.V. reported total assets of €77.2 million, against €92.8 million a year earlier (-16.9%). Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What are Centogene N.V.'s total liabilities?
- As of Dec 31, 2023, Centogene N.V. reported total liabilities of €102.4 million, against €85.4 million a year earlier (+19.9%). Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What are Centogene N.V.'s cash and cash equivalents?
- As of Dec 31, 2023, Centogene N.V. reported cash and cash equivalents of €19.1 million, against €36 million a year earlier (-46.9%). Source: the 20-F filed with the SEC on May 15, 2024. SEC
- What is Centogene N.V.'s total debt?
- As of Dec 31, 2023, Centogene N.V. reported total debt of €65.8 million, against €44.7 million a year earlier (+47.2%). Source: the 20-F filed with the SEC on May 15, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1757097&period_type=annual&limit=5"Information only, not investment advice.